Predictive Oncology (NASDAQ:POAI) reported quarterly losses of $(107.25) per share which missed the analyst consensus estimate of $(1.35) by 7844.44 percent. This is a 1377.27 percent decrease over losses of $(7.26) per share from the same period last year. The company reported $3.618 thousand in sales this quarter. This is a 7.40 percent decrease over sales of $3.907 thousand the same period last year.